<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND AIMS: <z:hpo ids='HP_0002020'>Gastroesophageal reflux disease</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>) reportedly has increased in prevalence while <z:hpo ids='HP_0005202'>Helicobacter pylori infection</z:hpo> and <z:hpo ids='HP_0004398'>peptic ulcer</z:hpo> disease have been on the decrease </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of the present study was to examine the prevalence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> as well as the clinical, endoscopic and histologic variables that associate with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> in patients referred for endoscopy </plain></SENT>
<SENT sid="2" pm="."><plain>PATIENTS AND METHODS: The study population was drawn from 1,562 consecutive patients referred for endoscopy </plain></SENT>
<SENT sid="3" pm="."><plain>The exclusion criteria were previous H. pylori eradication, gastric surgery, <z:hpo ids='HP_0001903'>anemia</z:hpo> and <z:hpo ids='HP_0001824'>weight loss</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Thus 1,128 patients were enrolled in the present study </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Of the 1,128 patients, 199 (18%) were referred for endoscopy due to heartburn and/or regurgitation </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>, defined as <z:hpo ids='HP_0011010'>chronic</z:hpo> (&gt;6 months) heartburn and/or regurgitation with or without erosive <z:hpo ids='HP_0100633'>esophagitis</z:hpo>, <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, <z:mp ids='MP_0004547'>esophageal ulcer</z:mp> or stricture, was detected in 248 (22%) patients </plain></SENT>
<SENT sid="7" pm="."><plain>Of the 248 GERD patients, 81 (33%) had endoscopy-negative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>, but of those aged &lt;50 years (n = 67), 57 (85%) were endoscopy-negative </plain></SENT>
<SENT sid="8" pm="."><plain>The overall incidence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> was 307 per 100,000 population/year and that of endoscopy-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> 207/100,000/year </plain></SENT>
<SENT sid="9" pm="."><plain>The positive and negative predictive values of heartburn and regurgitation for endoscopy-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> were 0.37 (95% CI 0.31-0.44) and 0.90 (95% CI 0.88-0.92), respectively </plain></SENT>
<SENT sid="10" pm="."><plain>Independent risk factors for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> were male sex (OR 1.9, 95% CI 1.3-2.7), previous medication for <z:e sem="disease" ids="C0857493" disease_type="Disease or Syndrome" abbrv="">upper gastrointestinal symptoms</z:e> (OR 2.7, 95% CI 1.7-4.1), the use of <z:chebi fb="2" ids="35475">nonsteroidal anti-inflammatory drugs</z:chebi> (<z:chebi fb="1" ids="35475">NSAIDs</z:chebi>; OR 2.0, 95% CI 1.3-3 </plain></SENT>
<SENT sid="11" pm="."><plain>0), histologic <z:hpo ids='HP_0100633'>esophagitis</z:hpo> (OR 2.2, 95% CI 1.5-3.2) and incomplete <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> at the gastroesophageal junction (OR 1.7, 95% CI 1.0-3.1) </plain></SENT>
<SENT sid="12" pm="."><plain><z:hpo ids='HP_0005231'>Chronic gastritis</z:hpo> was protective against <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> (OR 0.7, 95% CI 0.5-0.9) </plain></SENT>
<SENT sid="13" pm="."><plain>No association was observed between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> and H. pylori <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="14" pm="."><plain>The risk of patients aged &lt;50 years (n = 407) of having major lesion (<z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, <z:hpo ids='HP_0002043'>esophageal stricture</z:hpo>, <z:hpo ids='HP_0004398'>peptic ulcer</z:hpo>, esophageal/gastric <z:mp ids='MP_0002038'>carcinoma</z:mp>) was significantly lower than that of patients aged &gt;50 years (n = 721; OR 0.5, 95% CI 0.3-0 </plain></SENT>
<SENT sid="15" pm="."><plain>9, p = 0.01) </plain></SENT>
<SENT sid="16" pm="."><plain>CONCLUSIONS: The correlation between reflux symptoms and endoscopy-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> is poor and most <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> patients aged &lt;50 years have endoscopy-negative <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> </plain></SENT>
<SENT sid="17" pm="."><plain>The use of <z:chebi fb="1" ids="35475">NSAIDs</z:chebi> is a risk factor for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>, whereas <z:hpo ids='HP_0005231'>chronic gastritis</z:hpo>, but not H. pylori <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>, may protect against <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> </plain></SENT>
<SENT sid="18" pm="."><plain>Incomplete <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> at the gastroesophageal junction is associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> </plain></SENT>
</text></document>